- Home
- KMDA vs MCR Comparison
KMDA vs MCR Comparison
Compare KMDA & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- MCR
- Stock Information
- Founded
- KMDA 1990
- MCR 1989
- Country
- KMDA Israel
- MCR United States
- Employees
- KMDA N/A
- MCR N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- MCR Trusts Except Educational Religious and Charitable
- Sector
- KMDA Health Care
- MCR Finance
- Exchange
- KMDA Nasdaq
- MCR Nasdaq
- Market Cap
- KMDA 310.1M
- MCR 266.8M
- IPO Year
- KMDA N/A
- MCR N/A
- Fundamental
- Price
- KMDA $5.97
- MCR $6.39
- Analyst Decision
- KMDA Strong Buy
- MCR
- Analyst Count
- KMDA 2
- MCR 0
- Target Price
- KMDA $14.50
- MCR N/A
- AVG Volume (30 Days)
- KMDA 40.9K
- MCR 66.7K
- Earning Date
- KMDA 11-13-2024
- MCR 01-01-0001
- Dividend Yield
- KMDA N/A
- MCR 8.52%
- EPS Growth
- KMDA 230.67
- MCR N/A
- EPS
- KMDA 0.25
- MCR 0.38
- Revenue
- KMDA $154,574,000.00
- MCR N/A
- Revenue This Year
- KMDA $14.85
- MCR N/A
- Revenue Next Year
- KMDA $7.64
- MCR N/A
- P/E Ratio
- KMDA $22.94
- MCR $16.61
- Revenue Growth
- KMDA 6.01
- MCR N/A
- 52 Week Low
- KMDA $4.58
- MCR $5.63
- 52 Week High
- KMDA $6.53
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- KMDA 77.16
- MCR 46.98
- Support Level
- KMDA $5.84
- MCR $6.30
- Resistance Level
- KMDA $6.06
- MCR $6.38
- Average True Range (ATR)
- KMDA 0.12
- MCR 0.05
- MACD
- KMDA 0.07
- MCR 0.00
- Stochastic Oscillator
- KMDA 91.57
- MCR 69.67
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income. The fund invests the assets in debt instruments. It invests the assets in corporate bonds of U.S. and foreign issuers, U.S. Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S. and foreign issuers, and debt instruments of issuers located in emerging market countries.